sanofi buys us haemophilia treatment firm
Last Updated : GMT 09:03:51
Almaghrib Today, almaghrib today
Almaghrib Today, almaghrib today
Last Updated : GMT 09:03:51
Almaghrib Today, almaghrib today

For $11.6 bn

Sanofi buys US haemophilia treatment firm

Almaghrib Today, almaghrib today

Almaghrib Today, almaghrib today Sanofi buys US haemophilia treatment firm

Sanofi buys US haemophilia treatment firm for $11.6 bn
Paris - Al Maghrib Today

French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."

The purchase should also translate into a boost in profits per share beginning this year, rising to a gain of up to 5 percent in 2019, Sanofi said in a statement.

Bioverativ has latest-generation treatments for haemophilia, a disorder where blood does not clot properly to stop bleeding.

The haemophilia drugs market is "the largest market in rare diseases", worth around $10 billion per year and projected to grow by seven percent annually over the next five years, Brandicourt said in an audio conference with analysts.

He said he harboured a "strong admiration" for Bioverativ, which is a leader in the field with two drugs, Eloctate and Alprolix, already in the market and estimated overall sales of $1.2 billion in 2017.

Sanofi said it would be able to help Bioverativ with the research it has underway on the development of other haemophilia treatments, as well as for other rare diseases.

The agreement to purchase all of Bioverativ's outstanding shares for $105 each in cash represents a premium of 64 percent from the closing price on Friday, Sanofi said.

The operation is to start in February and close three months later, Brandicourt said.

But investors were not convinced, sending Sanofi's shares sharply lower on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table.

The deal "looks logical, but expensive", with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.

Furthermore, Sanofi may run into competition concerns from regulators with the takeover, they said.

The French firm said it would use funds on hand and borrow to finance the acquisition of Bioverativ.

But although pricey, the acquisition will still leave Sanofi with enough financial firepower to go after other acquisition targets, Jefferies said. One such target could be Pfizer's consumer healthcare business, they said.

The purchase of Bioverativ is the largest Sanofi has made since it acquired US biotech firm Genzyme for $20 billion in April 2011.

The French group failed in its 2016 bid to take over US cancer drugmaker Medivation which instead went to Pfizer.

Sanofi shares were 4.2 percent lower at 69.89 euros in late afternoon trading Monday, vastly underperforming the benchmark CAC 40 index in Paris which was up 0.2 percent.

Source: AFP

almaghribtoday
almaghribtoday

GMT 10:09 2018 Friday ,19 January

Police raid France's Lactalis

GMT 14:20 2018 Thursday ,18 January

Suppressing a sneeze can be dangerous

GMT 12:23 2018 Wednesday ,17 January

Populists target vaccine decree

GMT 12:39 2018 Tuesday ,16 January

Lactalis feels heat as families rebuff

GMT 12:01 2018 Monday ,15 January

Embattled dairy chief breaks silence

GMT 11:26 2018 Sunday ,14 January

One separated Gaza twin dies

GMT 11:31 2018 Saturday ,13 January

France laments 'dysfunction'

GMT 09:22 2018 Friday ,12 January

Cancer shatters gay marriage dreams
Almaghrib Today, almaghrib today

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Almaghrib Today, almaghrib today Skincare PR Performance Full Year 2017

GMT 09:22 2018 Monday ,22 January

Skincare PR Performance Full Year 2017
Almaghrib Today, almaghrib today New hunt for flight MH370 gets under way

GMT 11:03 2018 Wednesday ,24 January

New hunt for flight MH370 gets under way
Almaghrib Today, almaghrib today Modern colorful bedroom renovation

GMT 10:57 2017 Thursday ,21 December

Modern colorful bedroom renovation
Almaghrib Today, almaghrib today Puigdemont candidate for Catalan president

GMT 13:56 2018 Tuesday ,23 January

Puigdemont candidate for Catalan president
Almaghrib Today, almaghrib today Turkey detains dozens more

GMT 10:47 2018 Wednesday ,24 January

Turkey detains dozens more
Almaghrib Today, almaghrib today The Rake announces editorial updates

GMT 10:46 2018 Tuesday ,16 January

The Rake announces editorial updates
Almaghrib Today, almaghrib today Europe brings on charm and blue skies

GMT 11:51 2018 Tuesday ,23 January

Europe brings on charm and blue skies
Almaghrib Today, almaghrib today For the Variety of Interior Design Styles

GMT 10:46 2017 Tuesday ,19 December

For the Variety of Interior Design Styles
Almaghrib Today, almaghrib today US Christian tourists see deep meaning

GMT 13:44 2018 Monday ,22 January

US Christian tourists see deep meaning
Almaghrib Today, almaghrib today Amazon to open first cashierless shop

GMT 10:03 2018 Tuesday ,23 January

Amazon to open first cashierless shop

GMT 11:52 2017 Friday ,21 July

Radio Times appoints editorial director

GMT 12:45 2011 Sunday ,16 October

Habtoor Leighton wins $290m Qatar project deal

GMT 13:21 2017 Thursday ,22 June

Taiwan's Foxconn says Toshiba deal 'not over'

GMT 18:00 2017 Wednesday ,25 January

I can go the distance, says Dimitrov at Australian Open

GMT 15:05 2017 Wednesday ,25 January

Jordan condemns Somalia hotel attack

GMT 13:08 2017 Wednesday ,18 January

True love keeps her coming back for more

GMT 04:33 2017 Sunday ,26 February

Svitolina breaks into top 10 with Dubai win

GMT 22:01 2017 Wednesday ,01 March

Emotional farewell to former Wallabies lock Vickerman

GMT 17:50 2018 Wednesday ,03 January

King Salman receives Cypriot president

GMT 18:00 2017 Monday ,18 December

Wasps take revenge to halt La Rochelle

GMT 07:10 2013 Friday ,02 August

Ahmed Falawkas proud to work with Adel Emam

GMT 09:06 2017 Sunday ,15 October

Russia launches cargo ship to space station

GMT 17:33 2015 Thursday ,25 June

Laura Georges - France's World Cup 'rock'

GMT 01:48 2016 Thursday ,08 December

Israeli forces arrest 16 Palestinians in West Bank

GMT 13:05 2013 Monday ,05 August

Porsche voted \'Best Car Brand\' in the UK

GMT 17:15 2011 Thursday ,29 September

Reem Abdullah returns to screen

GMT 11:12 2011 Monday ,17 October

Abu Dhabi to construct 1,500MW power plant
Almaghrib Today, almaghrib today
 
 Almaghrib Today Facebook,almaghrib today facebook  Almaghrib Today Twitter,almaghrib today twitter Almaghrib Today Rss,almaghrib today rss  Almaghrib Today Youtube,almaghrib today youtube  Almaghrib Today Youtube,almaghrib today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

.almaghribtoday .almaghribtoday .almaghribtoday .almaghribtoday
almaghribtoday almaghribtoday almaghribtoday
almaghribtoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
almaghribtoday, Almaghribtoday, Almaghribtoday